{
  "source": "Comprehensive Pregnancy Categories Database",
  "description": "FDA pregnancy risk categories and safety information for medications",
  "extracted_at": "2025-10-05 16:23:22",
  "pregnancy_categories": [
    {
      "category": "Category A",
      "description": "Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy",
      "risk_level": "Lowest Risk",
      "examples": [
        "Folic acid",
        "Thyroid hormone (when used appropriately)",
        "Some vitamins and minerals"
      ],
      "notes": "Very few medications fall into this category"
    },
    {
      "category": "Category B",
      "description": "Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women",
      "risk_level": "Low Risk",
      "examples": [
        "Some antibiotics (penicillin, amoxicillin)",
        "Some antihistamines",
        "Some pain medications"
      ],
      "notes": "Generally considered safe during pregnancy"
    },
    {
      "category": "Category C",
      "description": "Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans",
      "risk_level": "Moderate Risk",
      "examples": [
        "Lamotrigine (Lamictal)",
        "Levetiracetam (Keppra)",
        "Many other medications"
      ],
      "notes": "Use only if potential benefit justifies potential risk"
    },
    {
      "category": "Category D",
      "description": "There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk",
      "risk_level": "High Risk",
      "examples": [
        "Valproic acid (Depakote)",
        "Carbamazepine (Tegretol)",
        "Phenytoin (Dilantin)"
      ],
      "notes": "Use only if no safer alternative exists"
    },
    {
      "category": "Category X",
      "description": "Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk",
      "risk_level": "Contraindicated",
      "examples": [
        "Isotretinoin (Accutane)",
        "Thalidomide",
        "Some chemotherapy drugs"
      ],
      "notes": "Should not be used during pregnancy"
    }
  ],
  "epilepsy_medication_categories": [
    {
      "medication": "Lamotrigine",
      "category": "Category C",
      "safety_notes": "Generally considered safer for pregnancy, may require dose adjustments"
    },
    {
      "medication": "Levetiracetam",
      "category": "Category C",
      "safety_notes": "Generally considered safer for pregnancy, good seizure control"
    },
    {
      "medication": "Valproic Acid",
      "category": "Category D",
      "safety_notes": "High risk of birth defects, should be avoided if possible"
    },
    {
      "medication": "Carbamazepine",
      "category": "Category D",
      "safety_notes": "Risk of neural tube defects, requires folic acid"
    },
    {
      "medication": "Phenytoin",
      "category": "Category D",
      "safety_notes": "Risk of fetal hydantoin syndrome, requires monitoring"
    }
  ],
  "general_guidelines": [
    "Pre-pregnancy counseling is essential",
    "Folic acid supplementation (5mg daily) before conception",
    "Regular monitoring of medication levels",
    "Multidisciplinary team approach",
    "Consider medication changes before pregnancy if possible",
    "Detailed anomaly scan at 18-20 weeks gestation",
    "Close monitoring throughout pregnancy"
  ]
}